Geode Capital Management, LLC Scynexis Inc Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
A detailed history of Geode Capital Management, LLC transactions in Scynexis Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 398,856 shares of SCYX stock, worth $502,558. This represents 0.0% of its overall portfolio holdings.
Number of Shares
398,856
Previous 362,451
10.04%
Holding current value
$502,558
Previous $724,000
17.96%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding SCYX
# of Institutions
52Shares Held
13.8MCall Options Held
34KPut Options Held
5K-
Federated Hermes, Inc. Pittsburgh, PA3.6MShares$4.53 Million0.01% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$2.82 Million0.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.69MShares$2.13 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.45MShares$1.83 Million0.14% of portfolio
-
Amh Equity LTD600KShares$756,0001.24% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $41.1M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...